Case Study: Hetero’s launch of Biosimilar ‘Bevacizumab’ Brand ‘Cizumab’ in India
Posted on28 Jun 2016
Comments0
Hetero, one of India’s leading generic pharmaceutical companies, today announces the launch of Biosimilar ‘Bevacizumab’ in India for the treatment of metastatic... Read More
Ranbaxy launches India’s first biosimilar of infliximab drug ‘Infimab’
Ranbaxy Laboratories has launched Infimab (BOWO15), the first “Remicade” (infliximab) biosimilar in India through a licensing partnership with Epirus Biopharmaceuticals, Inc., a... Read More